quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·49d
PRRelease
C4 Therapeutics Inc. logo
Immunocore Holdings plc logo
Iovance Biotherapeutics Inc. logo
+2

Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types

CCCC· C4 Therapeutics Inc.IMCR· Immunocore Holdings plcIOVA· Iovance Biotherapeutics Inc.ONCY· Oncolytics Biotech Inc.VIR· Vir Biotechnology Inc.
Health Care
Original source

Companies

  • CCCC
    C4 Therapeutics Inc.
    Health Care
  • IMCR
    Immunocore Holdings plc
    Health Care
  • IOVA
    Iovance Biotherapeutics Inc.
    Health Care
  • ONCY
    Oncolytics Biotech Inc.
    Health Care
  • VIR
    Vir Biotechnology Inc.
    Health Care

Recent analyst ratings

  • Mar 16IMCRUpdateJefferies$33.00
  • Feb 25IOVAUpdateCitizens$5.00
  • Feb 24VIRUpdateRaymond James$19.00
  • Jan 7IMCRUpdateUBS$55.00
  • Dec 2CCCCUpdateTD Cowen-
  • Oct 31IMCRUpdateWells Fargo$60.00

Related

  • PR17h
    Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
  • SEC1d
    Amendment: SEC Form SCHEDULE 13G/A filed by C4 Therapeutics Inc.
  • PR4d
    KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
  • PR6d
    Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
  • SEC6d
    SEC Form PRE 14A filed by Iovance Biotherapeutics Inc.
  • SEC7d
    SEC Form DEF 14A filed by Immunocore Holdings plc
  • SEC8d
    SEC Form DEFA14A filed by Vir Biotechnology Inc.
  • SEC8d
    SEC Form DEF 14A filed by Vir Biotechnology Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022